{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T12:07:23Z","timestamp":1698667643662},"reference-count":31,"publisher":"FapUNIFESP (SciELO)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Hosp. Clin."],"published-print":{"date-parts":[[2002,9]]},"abstract":"<jats:p>OBJECTIVES: To determine the efficacy of a simple, short-term and low-cost eradication treatment for Helicobacter pylori (H. pylori) using omeprazole, tetracycline, and furazolidone in a Brazilian peptic ulcer population, divided into 2 subgroups: untreated and previously treated for the infection. PATIENTS AND METHODS: Patients with peptic ulcer disease diagnosed by endoscopic examination and infected by H. pylori diagnosed by the rapid urease test (RUT) and histological examination, untreated and previously unsuccessfully treated by macrolides and nitroimidazole, were medicated with omeprazole 20 mg daily dose and tetracycline 500 mg and furazolidone 200 mg given 3 times a day for 7 days. Another endoscopy or a breath test was performed 12 weeks after the end of treatment. Patients were considered cured of the infection if a RUT and histologic examination proved negative or a breath test was negative for the bacterium. RESULTS: Sixty-four patients were included in the study. The women were the predominant sex (58%); the mean age was 46 years. Thirty-three percent of the patients were tobacco users, and duodenal ulcer was identified in 80% of patients. For the 59 patients that underwent follow-up examinations, eradication was verified in 44 (75%). The eradication rate for the intention-to-treat group was 69%. The incidence of severe adverse effects was 15%. CONCLUSION: The treatment provides good efficacy for H. pylori eradication in patients who were previously treated without success, but it causes severe adverse effects that prevented adequate use of the medications in 15% of the patients.<\/jats:p>","DOI":"10.1590\/s0041-87812002000500003","type":"journal-article","created":{"date-parts":[[2005,4,27]],"date-time":"2005-04-27T13:22:27Z","timestamp":1114608147000},"page":"205-208","source":"Crossref","is-referenced-by-count":12,"title":["Omeprazole, Furazolidone, and Tetracycline: an eradication treatment for resistant H. pylori in Brazilian patients with peptic ulcer disease"],"prefix":"10.1590","volume":"57","author":[{"given":"Fernando Marcuz","family":"Silva","sequence":"first","affiliation":[{"name":"University of S\u00e3o Paulo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaime Natan","family":"Eisig","sequence":"additional","affiliation":[{"name":"University of S\u00e3o Paulo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ethel Zimberg","family":"Chehter","sequence":"additional","affiliation":[{"name":"University of S\u00e3o Paulo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00falio Jovino da","family":"Silva","sequence":"additional","affiliation":[{"name":"University of S\u00e3o Paulo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio At\u00edlio","family":"Laudanna","sequence":"additional","affiliation":[{"name":"University of S\u00e3o Paulo"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1046\/j.1365-2036.1996.40182000.x","article-title":"Review article: clinic aspectcs of Helicobacter pylori eradication therapy in peptic ulcer disease","volume":"10(suppl 4)","author":"PENSTON JG","year":"1996","journal-title":"Aliment Pharmacol Ther","ISSN":"http:\/\/id.crossref.org\/issn\/0269-2813","issn-type":"print"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1159\/000007522","article-title":"Treatment of peptic ulcer","volume":"59","author":"TYTGAT GN","year":"1998","journal-title":"Digestion","ISSN":"http:\/\/id.crossref.org\/issn\/0012-2823","issn-type":"print"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1046\/j.1365-2036.1996.95267000.x","article-title":"Helicobacter pylori eradication in clinical practice: one-week low-dose triple therapy is preferable to classical bismuth based triple therapy","volume":"10","author":"GODDARD AF","year":"1996","journal-title":"Aliment Pharmacol Ther","ISSN":"http:\/\/id.crossref.org\/issn\/0269-2813","issn-type":"print"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3109\/00365529609094747","article-title":"Pooled analysis of anti-Helicobacter pylori treatment regimens","volume":"31","author":"UNGE P","year":"1996","journal-title":"Scand J Gastroentrol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1523-5378.1996.tb00003.x","article-title":"Treatment of Helicobacter pylori infection: A review of the World literature","volume":"1","author":"VAN DER HULST RWM","year":"1996","journal-title":"Helicobacter","ISSN":"http:\/\/id.crossref.org\/issn\/1083-4389","issn-type":"print"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1046\/j.1365-2036.2000.00798.x","article-title":"Review article: treatment of Helicobacter pylori infection with ranitidine bismuth citrate or proton pump inhibitor-based triple therapies","volume":"14","author":"VAN OIJEN AHAM","year":"2000","journal-title":"Aliment Pharmacol Ther","ISSN":"http:\/\/id.crossref.org\/issn\/0269-2813","issn-type":"print"},{"key":"ref7","first-page":"A118","article-title":"H. pylori eradication: High efficacy week treatment with clarithromycin 500 mg bid, amoxicillin 1.0 g bid plus lansoprazole 30 mg bid in S\u00e3o Paulo -- Brazil","volume":"94","author":"CHEHTER EZ","year":"1999","journal-title":"Am J Gastroenterol","ISSN":"http:\/\/id.crossref.org\/issn\/0002-9270","issn-type":"print"},{"key":"ref8","first-page":"322","article-title":"Metronidazole-resistant Helicobacter pylori in a developing country","volume":"88","author":"QUEIROZ DMM","year":"1993","journal-title":"Am J Gastroenterol","ISSN":"http:\/\/id.crossref.org\/issn\/0002-9270","issn-type":"print"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1023\/A:1018882804607","article-title":"Metronidazole resistance reduces efficacy of triple therapy and leads to secondary clarithromycin resistance","volume":"42","author":"BUCKLEY MJM","year":"1997","journal-title":"Dig Dis Sci","ISSN":"http:\/\/id.crossref.org\/issn\/0163-2116","issn-type":"print"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1128\/AAC.45.1.306-308.2001","article-title":"Furazolidone- and nitrofurantoin-resistant Helicobacter pylori: prevalence and role of genes involved in metronidazole resistance","volume":"45","author":"KWON DH","year":"2001","journal-title":"Antimicrob Agents Chemother","ISSN":"http:\/\/id.crossref.org\/issn\/0066-4804","issn-type":"print"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1046\/j.1523-5378.2000.00011.x","article-title":"Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxicillin, tetracycline, and furazolidone in Brazil","volume":"5","author":"MENDON\u00c7A S","year":"2000","journal-title":"Helicobacter","ISSN":"http:\/\/id.crossref.org\/issn\/1083-4389","issn-type":"print"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1046\/j.1365-2036.2001.01064.x","article-title":"Review article: alternative antibacterial agents for Helicobacter pylori eradication","volume":"15","author":"GUSLANDI M","year":"2001","journal-title":"Aliment Pharmacol Ther","ISSN":"http:\/\/id.crossref.org\/issn\/0269-2813","issn-type":"print"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1046\/j.1365-2036.1997.00172.x","article-title":"Furazolidone, amoxycillin, bismuth triple therapy for Helicobacter pylori infection","volume":"11","author":"SEGURA AM","year":"1997","journal-title":"Aliment Pharmacol Ther","ISSN":"http:\/\/id.crossref.org\/issn\/0269-2813","issn-type":"print"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1046\/j.1365-2036.2000.00640.x","article-title":"Furazolidone combination therapies for Helicobacter pylori infection in the United States","volume":"14","author":"GRAHAM DY","year":"2000","journal-title":"Aliment Pharmacol Ther","ISSN":"http:\/\/id.crossref.org\/issn\/0269-2813","issn-type":"print"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"pH30","DOI":"10.1046\/j.1440-1746.2000.000s2.x","article-title":"When Helicobacter pylori (hp) eradication fails: what to do next","volume":"15","author":"MARSHALL BJ","year":"2000","journal-title":"J Gastroenterol Hepatol","ISSN":"http:\/\/id.crossref.org\/issn\/0815-9319","issn-type":"print"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1046\/j.1365-2036.1999.00653.x","article-title":"Omeprazole, clarithromycin and furazolidone for the eradication of Helicobacter pylori in patients with duodenal ulcer","volume":"13","author":"DANI R","year":"1999","journal-title":"Aliment Pharmacol Ther","ISSN":"http:\/\/id.crossref.org\/issn\/0269-2813","issn-type":"print"},{"key":"ref17","first-page":"162","article-title":"Five-day and ten-day triple therapy (amoxicillin, furazolidone and metronidazole) in the treatment of duodenal ulcer","volume":"51","author":"ZATERKA S","year":"1996","journal-title":"Rev Hosp Clin Fac Med S Paulo"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3109\/00365529209000088","article-title":"Duodenal ulcer and eradication of Helicobacter pylori in a developing country: An 18-month follow-up study","volume":"27","author":"COELHO LG","year":"1992","journal-title":"Scand J Gastroenterol","ISSN":"http:\/\/id.crossref.org\/issn\/0036-5521","issn-type":"print"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1046\/j.1365-2036.2001.00931.x","article-title":"Clarithromycin vs. furazolidone in quadruple therapy regimens for the treatment of Helicobacter pylori in a population with a high metronidazole resistance rate","volume":"15","author":"FAKHERI H","year":"2001","journal-title":"Aliment Pharmacol Ther","ISSN":"http:\/\/id.crossref.org\/issn\/0269-2813","issn-type":"print"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1155\/1999\/485237","article-title":"Helicobacter pylori: novel therapies","volume":"13","author":"DROUIN E","year":"1999","journal-title":"Can J Gastroenterol","ISSN":"http:\/\/id.crossref.org\/issn\/0835-7900","issn-type":"print"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1046\/j.1365-2036.2001.00895.x","article-title":"A multicentre study on eradication of Helicobacter pylori using four 1-week triple therapies in China","volume":"15","author":"XIAO SD","year":"2001","journal-title":"Aliment Pharmacol Ther","ISSN":"http:\/\/id.crossref.org\/issn\/0269-2813","issn-type":"print"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1046\/j.1365-2036.1999.00487.x","article-title":"High cure rate of Helicobacter pylori infection using tripotassium dicitrato bismuthate, furazolidone and charithoymcin triple therapy for 1 week","volume":"13","author":"XIAO SD","journal-title":"Aliment Pharmacol Ther","ISSN":"http:\/\/id.crossref.org\/issn\/0269-2813","issn-type":"print"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/S0140-6736(85)91865-3","article-title":"Rapid diagnosis of Campilobacter pylori","volume":"1","author":"MCNULTY CAM","year":"1985","journal-title":"Lancet","ISSN":"http:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1590\/S0036-46651999000100002","article-title":"Validation of 14C-urea breath test for diagnosis of Helicobacter pylori","volume":"41","author":"MATTAR R","year":"1999","journal-title":"Rev Inst Med Trop S. Paulo"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1001\/archinte.1995.00430090057007","article-title":"Costs of duodenal ulcer therapy with antibiotics","volume":"155","author":"SONNENBERG A","year":"1995","journal-title":"Arch Intern Med","ISSN":"http:\/\/id.crossref.org\/issn\/0003-9926","issn-type":"print"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"52S","DOI":"10.1016\/S0002-9343(96)80229-4","article-title":"Helicobacter pylori and complicated ulcer disease","volume":"100","author":"LAINE LA","year":"1996","journal-title":"Am J Med","ISSN":"http:\/\/id.crossref.org\/issn\/0002-9343","issn-type":"print"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"705","DOI":"10.7326\/0003-4819-116-9-705","article-title":"Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer: A randomized, controlled study","volume":"116","author":"GRAHAM DY","year":"1992","journal-title":"Ann Intern Med","ISSN":"http:\/\/id.crossref.org\/issn\/0003-4819","issn-type":"print"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1080\/003655201300191941","article-title":"Pooled analysis on the efficacy of the second-line treatment regimens for Helicobacter pylori infection","volume":"36","author":"HOJO M","year":"2001","journal-title":"Scand J Gastroenterol","ISSN":"http:\/\/id.crossref.org\/issn\/0036-5521","issn-type":"print"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1097\/00042737-199909000-00018","article-title":"Re-treatment after Helicobacter pylori eradication failure","volume":"11","author":"GISBERT JP","year":"1999","journal-title":"Eur J Gastroenterol Hepatol","ISSN":"http:\/\/id.crossref.org\/issn\/0954-691X","issn-type":"print"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1590\/S0041-87812001000100003","article-title":"Factors affecting Helicobacter pylori eradication using a seven-day triple therapy with a proton pump inhibitor, tinidazole and clarithomycin, in Brazilian patients with peptic ulcer","volume":"56","author":"SILVA FM","year":"2001","journal-title":"Rev Hosp Clin Fac Med S. Paulo"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1128\/AAC.34.9.1637","article-title":"In vitro selection of resistant Helicobacter pylori","volume":"34","author":"HAAS CE","year":"1990","journal-title":"Antimicrob Agents Chemother","ISSN":"http:\/\/id.crossref.org\/issn\/0066-4804","issn-type":"print"}],"container-title":["Revista do Hospital das Cl\u00ednicas"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/rhc\/v57n5\/13013.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,24]],"date-time":"2017-05-24T22:19:41Z","timestamp":1495664381000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0041-87812002000500003&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,9]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2002,9]]}},"alternative-id":["S0041-87812002000500003"],"URL":"https:\/\/doi.org\/10.1590\/s0041-87812002000500003","relation":{},"ISSN":["0041-8781"],"issn-type":[{"value":"0041-8781","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,9]]}}}